Benzinga··Vandana SinghIonis Slashes Tryngolza Price 93% Ahead of FDA Label Expansion Decision
Ionis Pharmaceuticals cuts Tryngolza price from $595K to $40K annually, positioning for broader FDA approval and potential $2B+ peak sales.
IONSFDA approvalmarket expansion